Long-term clinical efficacy of mild hypothermia therapy in neonates with hypoxic-ischemic encephalopathy: a Meta analysis

CAO Chang-Qing; LI Yu-Ning; YANG Xue-Mei; GONG Yi-Gu; WANG Fang; LI Wei-Guo

doi:10.7499/j.issn.1008-8830.2015.02.003

PDF(1168 KB)

Chinese Journal of Contemporary Pediatrics ›› 2015, Vol. 17 ›› Issue (2) : 122-127. DOI: 10.7499/j.issn.1008-8830.2015.02.003

CLINICAL RESEARCH

Long-term clinical efficacy of mild hypothermia therapy in neonates with hypoxic-ischemic encephalopathy: a Meta analysis

CAO Chang-Qing, LI Yu-Ning, YANG Xue-Mei, GONG Yi-Gu, WANG Fang, LI Wei-Guo

Author information +

History +

Abstract

Objective To systematically evaluate the long-term clinical efficacy and safety of mild hypothermia therapy in neonates with hypoxic-ischemic encephalopathy (HIE). Methods All randomized controlled trials (RCTs) of mild hypothermia therapy for neonatal HIE from inception to March 2014 were retrieved from databases including Cochrane Library, PubMed, Embase, CBMdisc, and Wanfang Data. Meta analysis was performed using RevMan 5.1 Software. Results Eight RCTs met the search criteria. The results of Meta analysis showed that, compared with the control group, systemic hypothermia significantly reduced the mortality rate and the incidence of growth delay (RR=0.73, 95% CI: 0.61-0.89; RR=0.70, 95%CI: 0.54-0.93); selective head or systemic hypothermia therapy significantly reduced the incidence of cerebral palsy (RR=0.65, 95%CI: 0.46-0.94; RR=0.67, 95%CI: 0.52-0.86) up to 12-24 months of age. One study reported that hypothermia reduced the mortality rate and the rate of a composite end point of death or severe disability compared with the control group at 6 to 7 years of age. The incidence of adverse events including sinus bradyarrhythmia, thrombocytopenia and hypoglycemia was significantly higher in the hypothermia group than in the control group, whereas the incidence of cardiac arrhythmia, hypotension, thrombosis or bleeding, hypokalemia, sepsis, and liver dysfunction showed no significant differences between the two groups. Conclusions Mild hypothermia therapy demonstrates a significant efficacy in children with HIE up to 12-24 months of age, but there is still a need for further research on childhood outcomes after mild hypothermia for neonatal HIE. This therapy has few adverse effects and a high clinical tolerability.

Key words

Mild hypothermia / Hypoxic-ischemic encephalopathy / Meta analysis / Neonate

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

CAO Chang-Qing, LI Yu-Ning, YANG Xue-Mei, GONG Yi-Gu, WANG Fang, LI Wei-Guo. Long-term clinical efficacy of mild hypothermia therapy in neonates with hypoxic-ischemic encephalopathy: a Meta analysis[J]. Chinese Journal of Contemporary Pediatrics. 2015, 17(2): 122-127 https://doi.org/10.7499/j.issn.1008-8830.2015.02.003

References

[1] 张鹏, 程国强. 亚低温治疗新生儿缺氧缺血性脑病的研究进展[J]. 中国当代儿科杂志, 2013, 15(10): 918-922.
[2] 刘翠青, 夏耀方, 袁玉肖, 等. 头部亚低温对新生儿缺氧缺血性脑病半胱氨酸蛋白酶-3和白介素-18的影响[J]. 中国当代儿科杂志, 2010, 12(9): 690-692.
[3] 王英娟, 潘凯丽, 赵晓莉, 等. 促红细胞生成素治疗新生儿缺氧缺血性脑病疗效观察[J].中国当代儿科杂志, 2011, 13(11): 855-858.
[4] 王来栓, 程国强, 周文浩. 亚低温治疗胎龄大于35周龄新生儿缺氧缺血性脑病效果及安全性的荟萃分析[J].中华医学杂志, 2012, 92(20): 1400-1404.
[5] 中华医学会儿科学分会新生儿学组. 新生儿缺氧缺血性脑病诊断标准[J].中国当代儿科杂志, 2005, 7(2): 97-98.
[6] 母得志. 新生儿缺氧缺血性脑病的诊断和治疗[J]. 实用儿科临床杂志, 2011, 26(14): 1144-1147.
[7] Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions: version 5.1.0[DB/OL]. Cochrane Collaboration, 2011. http://www.cochrane-handbook.org/.
[8] Battin MR, Penrice J, Gunn TR, et al. Treatment of term infants with head cooling and mild systemic hypothermia (35.0 degrees C and 34.5 degrees C) after perinatal asphyxia[J]. Pediatrics, 2003, 111(2): 244-251.
[9] Shankaran S, Pappas A, Laptook AR, et al. Outcomes of safety and effectiveness in a multicenter randomized, controlled trial of whole-body hypothermia for neonatal hypoxic-ischemic encephalopathy[J]. Pediatrics, 2008, 122(4): e791-e798.
[10] Jacobs SE, Morley CJ, Inder TE, et al. Whole-body hypothermia for term and near-term newborns with hypoxic-ischemic encephalopathy: a randomized controlled trial[J]. Arch Pediatr Adolesc Med, 2011, 165(8): 692-700.
[11] Simbruner G, Mittal RA, Rohlmann F, et al. Systemic hypothermia after neonatal encephalopathy: outcomes of neo.nEURO.network RCT[J]. Pediatrics, 2010, 126(4): e771-e778.
[12] Gluckman PD, Wyatt JS, Azzopardi D, et al. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial[J]. Lancet, 2005, 365(9460): 663-670.
[13] Eicher DJ, Wagner CL, Katikaneni LP, et al. Moderate hypothermia in neonatal encephalopathy: efficacy outcomes[J]. Pediatr Neurol, 2005, 32(1): 11-17.
[14] Zhou WH, Cheng GQ, Shao XM, et al. Selective head cooling with mild systemic hypothermia after neonatal hypoxic-ischemic encephalopathy: a multicenter randomized controlled trial in China[J]. J Pediatr, 2010, 157(3): 367-372.
[15] Azzopardi DV, Strohm B, Edwards AD, et al. Moderate hypothermia to treat perinatal asphyxial encephalopathy[J]. N Engl J Med, 2009, 361(14): 1349-1358.
[16] Guillet R, Edwards AD, Thoresen M, et al. Seven- to eight-year follow-up of the CoolCap trial of head cooling for neonatal encephalopathy[J]. Pediatr Res, 2012, 71(2):205-209.
[17] Shankaran S, Pappas A, McDonald SA, et al. Childhood outcomes after hypothermia for neonatal encephalopathy[J]. N Engl J Med, 2012, 366(22): 2085-2092.
[18] 尤嘉, 刘俐, 张明, 等. T1WI信号强度与1H MRS在新生儿缺氧缺血性脑病诊断中的价值[J].中国当代儿科杂志, 2011, 13(2): 107-110.
[19] 林碧云, 张鹏, 程国强, 等. 大于35周胎龄新生儿缺氧缺血性脑病远期预后评价体系荟萃分析[J]. 中华医学杂志, 2014, 94(2): 115-121.
[20] van Laerhoven H, de Haan TR, Offringa M, et al. Prognostic tests in term neonates with hypoxic-ischemic encephalopathy: a systematic review[J]. Pediatrics, 2013, 131(1): 88-98.
[21] Galvao TF, Silva MT, Marques MC, et al. Hypothermia for perinatal brain hypoxia-ischemia in different resource settings: a systematic review[J]. J Trop Pediatr, 2013, 59(6): 453-459.